Literature DB >> 16582929

Plasmodium post-genomics: better the bug you know?

Taco W A Kooij1, Chris J Janse, Andrew P Waters.   

Abstract

Since the publication of the sequence of the genome of Plasmodium falciparum, the major causative agent of human malaria, many post-genomic studies have been completed. Invaluably, these data can now be analysed comparatively owing to the availability of a significant amount of genome-sequence data from several closely related model species of Plasmodium and accompanying global proteome and transcriptome studies. This review summarizes our current knowledge and how this has already been--and will continue to be--exploited in the search for vaccines and drugs against this most significant infectious disease of the tropics.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16582929     DOI: 10.1038/nrmicro1392

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  27 in total

1.  In silico analysis for structure, function and T-cell epitopes of a hypothetical conserved (HP-C) protein coded by PVX_092425 in Plasmodium vivax.

Authors:  Jinyu Mo; Jian Li
Journal:  Pathog Glob Health       Date:  2015-02-23       Impact factor: 2.894

2.  Melatonin and IP3-induced Ca2+ release from intracellular stores in the malaria parasite Plasmodium falciparum within infected red blood cells.

Authors:  Eduardo Alves; Paula J Bartlett; Celia R S Garcia; Andrew P Thomas
Journal:  J Biol Chem       Date:  2010-12-13       Impact factor: 5.157

3.  Proteomic analysis of zygote and ookinete stages of the avian malaria parasite Plasmodium gallinaceum delineates the homologous proteomes of the lethal human malaria parasite Plasmodium falciparum.

Authors:  Kailash P Patra; Jeff R Johnson; Greg T Cantin; John R Yates; Joseph M Vinetz
Journal:  Proteomics       Date:  2008-06       Impact factor: 3.984

4.  Fine-scale genetic characterization of Plasmodium falciparum chromosome 7 encompassing the antigenic var and the drug-resistant pfcrt genes.

Authors:  Ruchi Bajaj; Sujata Mohanty; A P Dash; Aparup Das
Journal:  J Genet       Date:  2008-04       Impact factor: 1.166

Review 5.  Malaria: progress, perils, and prospects for eradication.

Authors:  Brian M Greenwood; David A Fidock; Dennis E Kyle; Stefan H I Kappe; Pedro L Alonso; Frank H Collins; Patrick E Duffy
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

6.  Biosynthesis of GDP-fucose and other sugar nucleotides in the blood stages of Plasmodium falciparum.

Authors:  Sílvia Sanz; Giulia Bandini; Diego Ospina; Maria Bernabeu; Karina Mariño; Carmen Fernández-Becerra; Luis Izquierdo
Journal:  J Biol Chem       Date:  2013-04-24       Impact factor: 5.157

7.  Distinct genomic architecture of Plasmodium falciparum populations from South Asia.

Authors:  Shiva Kumar; Devaraja G Mudeppa; Ambika Sharma; Anjali Mascarenhas; Rashmi Dash; Ligia Pereira; Riaz Basha Shaik; Jennifer N Maki; John White; Wenyun Zuo; Shripad Tuljapurkar; Manoj T Duraisingh; Edwin Gomes; Laura Chery; Pradipsinh K Rathod
Journal:  Mol Biochem Parasitol       Date:  2016-07-22       Impact factor: 1.759

8.  Discovering regulatory motifs in the Plasmodium genome using comparative genomics.

Authors:  Jie Wu; Douglas H Sieglaff; Joshua Gervin; Xiaohui S Xie
Journal:  Bioinformatics       Date:  2008-07-08       Impact factor: 6.937

9.  Characterization of a conserved rhoptry-associated leucine zipper-like protein in the malaria parasite Plasmodium falciparum.

Authors:  Silvia Haase; Ana Cabrera; Christine Langer; Moritz Treeck; Nicole Struck; Susann Herrmann; Pascal W Jansen; Iris Bruchhaus; Anna Bachmann; Suzana Dias; Alan F Cowman; Hendrik G Stunnenberg; Tobias Spielmann; Tim-Wolf Gilberger
Journal:  Infect Immun       Date:  2008-01-03       Impact factor: 3.441

10.  Recombinant peptide replicates immunogenicity of synthetic linear peptide chimera for use as pre-erythrocytic stage malaria vaccine.

Authors:  Luciana M Silva-Flannery; Monica Cabrera-Mora; Jianlin Jiang; Alberto Moreno
Journal:  Microbes Infect       Date:  2008-10-26       Impact factor: 2.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.